Egyptian Company for Medical Investments

What Egyptian Company for Medical Investments does

Egyptian Company for Medical Investments (ECMI) is a state-affiliated healthcare investment holding company incorporated in Egypt in 2020 under the Egyptian Authority for Unified Purchasing, Medical Supply and Provision and Medical Technology Management (UPA). It operates as the parent of two core distribution subsidiaries — Egyptian Pharmaceutical Trading Company (EPTC, founded 1965), which is the sole authorized distributor of psychotropic and narcotic medicines in Egypt and a key supplier of infant formula, therapeutic milk, and insulin; and El Gomhouria Company for Pharmaceuticals, Chemicals and Medical Supplies (GOMCO, founded 1963), the largest importer and distributor of medical devices, chemicals, and laboratory equipment in Egypt, representing more than 60 international OEMs through 18 showrooms and sales branches. ECMI also manages a network of strategic medical warehouses across six governorates (Cairo, Alexandria, Dakahlia, Qena, Minya, Ismailia) owned jointly with the UPA, the Sovereign Fund of Egypt, and the Armed Forces Land Projects Authority, and operates the Esaaf 24 retail pharmacy chain serving approximately 500,000 patients annually with scarce and controlled medications.

ECMI makes money primarily through distribution margins on pharmaceutical and medical-equipment sales via public tenders to government entities — including the Egyptian Military, health insurance bodies, and university hospitals — and through retail pharmacy sales and managed-services fees for strategic warehouse operations. Its go-to-market is sales-led and tender-driven rather than commercial or product-led, anchored by its regulatory franchise rather than brand or technology. Recent strategic activity includes a 2025 joint venture with Japan's JMS and Inter-Pharm to manufacture blood collection bags locally, a 2024 MoU with Saudi Arabia's Medical Care Portal to deploy the HEC digital healthcare platform, expansion of the Esaaf 24 pharmacy chain toward nationwide coverage, and active participation in the SWMP track-and-trace program for medical products. The stated vision is to become Egypt's leading healthcare investment company through localization of pharmaceutical and medical-supply manufacturing, geographic expansion across Africa and the Arab world, and digital transformation of healthcare delivery.

Name

Egyptian Company for Medical Investments

Legal name

Egyptian Company for Medical Investments (ECMI)

Website

https://ecmi.com.eg

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

ECMI is an Egyptian state-affiliated healthcare investment holding company, parent of EPTC (the sole authorized psychotropic/narcotic drug distributor) and GOMCO (the largest medical equipment importer, representing 60+ international OEMs), serving government hospitals and Egyptian citizens through tenders, pharmacies, and strategic warehouses.

Ownership category

akta.pro rank

Headquarters

HQ city

Cairo

HQ country

Egypt

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Distribution: EPTC distributes pharmaceutical products across Egypt, including psychotropic and narcotic medicines (only authorized company), infant formula, therapeutic milk, and insulin. Revenue is generated through distribution margins on drug sales to pharmacies, hospitals, and government bodies.
2. Medical Equipment & Supplies Distribution: GOMCO imports and supplies chemicals, medical devices, scientific and laboratory equipment, representing over 60 international companies. Services cover the Egyptian market through 18 showrooms and sales branches, supplying military, health insurance, university hospitals, and public/private sectors via public tenders.
3. Strategic Warehouse Management: ECMI manages the system of strategic warehouses for medical products and devices established with state entities, maximizing utilization of the state's strategic stock of pharmaceuticals and medical supplies. Revenue derives from government contracts and service fees.
4. Retail Pharmacy Chain: Operation of Esaaf 24 Pharmacies (under EPTC), serving approximately half a million patients annually with medications scarce in the Egyptian market, psychotropic drugs, baby formula, insulin, and cancer medications. Revenue from retail pharmacy sales.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

ECMI is a state-owned healthcare investment holding company that operates EPTC (Egyptian Pharmaceutical Trading Company) for pharmaceutical distribution — including the sole authorized role for psychotropic and narcotic medicines — and GOMCO for medical equipment and supplies. It also manages a network of strategic medical warehouses across Egypt and runs the small Esaaf 24 retail pharmacy chain.

Product overview

ECMI operates as a healthcare investment holding company with two main subsidiaries—Egyptian Pharmaceutical Trading Company (EPTC) and El Gomhouria Company (GOMCO). EPTC handles pharmaceutical distribution including controlled substances and essential medicines, while GOMCO focuses on medical equipment and supplies distribution. The company also operates the Esaaf 24 retail pharmacy chain, manages strategic warehouses across six governorates, and is developing local manufacturing capabilities including blood bag production. The company is also implementing a digital healthcare system (HEC) for comprehensive health data management.

Differentiator

Problem solved

Functional benefit

Brands

• Esaaf 24 Pharmacies: 24/7 pharmacy chain operated by EPTC, offering medications including scarce drugs, infant formula, therapeutic milk, insulin, and cancer medications; serves approximately half a million patients annually.

Products and services

• EPTC Pharmaceutical Distribution

Quantifiable outcome

• ~500,000 patients served annually through Esaaf Pharmacies
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core, strategic and minor.

• SWMP (Strategic Warehouses for Medical Products and Devices Program)coreStrategic or Co-development Partner · 22 June 2026ECMI actively participates alongside the SWMP program. Dr. Osama Abdelbaset, Chairman and CEO of ECMI, attended the Origen Technology Summit on 22 June 2026 for track and trace of medical products and devices, demonstrating ECMI's active role in the SWMP initiative.
• JMS (Japan Medical Supplies)coreStrategic or Co-development Partner · 1 May 2025A joint cooperation agreement was signed between ECMI, Japanese company JMS (global leader in manufacturing high-quality blood collection bags and medical supplies), and Inter-Pharm for Medical Export, Import and Trade (exclusive agent for JMS Japan). The agreement aims to manufacture blood collection bags locally in Egypt according to international standards. The project will involve technology transfer and localization, with a partnership between the Holding Company for Pharmaceuticals, the Unified Procurement Authority, and private sector companies to meet local market needs and export to African and Arab markets.
• Inter-Pharm for Medical IndustriescoreStrategic or Co-development Partner · 1 May 2025Inter-Pharm for Medical Export, Import, and Trade served as the exclusive agent for JMS Japan in the blood bag manufacturing partnership. Inter-Pharm signed alongside ECMI and JMS. Dr. Ahmed Samy is Chairman of Inter-Pharm.
• Medical Care Portal (MCP) - Software Makers LimitedstrategicTechnology or Integration · 4 April 2024A memorandum of understanding was signed between ECMI and Medical Care Portal (a company of Software Makers Limited, Kingdom of Saudi Arabia) for digital transformation of the health and pharmaceutical sector and localization of medical industries. MCP will provide the HEC project to build an interactive digital system including hospitals, clinics, health centers, and medical service providers for comprehensive healthcare management, digital medical files, and big data organization.
• Holding Company for Pharmaceuticals (Egypt)strategicStrategic or Co-development PartnerECMI partners with the Holding Company for Pharmaceuticals as part of the blood bag manufacturing project and broader pharmaceutical localization initiatives. The partnership leverages the Holding Company's diverse assets for joint cooperation to serve the national economy.
• Egyptian Authority for Unified PurchasingcoreStrategic or Co-development PartnerECMI was established by and operates under the Egyptian Authority for Unified Purchasing, Medical Supply and Provision, and Medical Technology Management. ECMI manages transport and distribution of medical preparations procured by the Authority and manages the strategic warehouse system.
• DAF (Digital Solutions Company)minorStrategic or Co-development PartnerDAF is an Egyptian digital solutions company primarily focused on enhancing healthcare and pharmaceutical sectors while promoting financial inclusion. It is listed as an affiliate of ECMI. Its mission is to create accessible solutions through digital technology to address key challenges in vital areas of the country.
• Strategic Warehouses CompanycoreStrategic or Co-development PartnerThe Strategic Warehouses Company is affiliated with the Egyptian Unified Procurement Authority, the Sovereign Fund of Egypt, and the Armed Forces Land Projects Authority. It owns warehouses distributed across 6 governorates (Cairo, Alexandria, Dakahlia, Qena, Minya, Ismailia). ECMI manages the strategic warehouse system established with state entities.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer with government backing and MENA distribution. Comparable to ECMI as a Gulf state-affiliated pharma enterprise operating regional pharmaceutical distribution and manufacturing.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): State-affiliated Saudi pharmaceutical manufacturer and distributor with MENA-wide operations. Comparable to ECMI as a government-linked pharmaceutical enterprise in a neighboring MENA market with similar scale and national healthcare role.

Broad incumbents

• Cardinal Health: One of the largest pharmaceutical and medical product distributors globally. Comparable to ECMI's GOMCO subsidiary in medical equipment and supplies distribution, though at vastly larger scale.
• McKesson Corporation: Global pharmaceutical distribution and healthcare services leader. Comparable to ECMI as a large-scale pharmaceutical and medical supply distributor, though operating at vastly greater scale in private markets.
• Hikma Pharmaceuticals: Leading MENA-headquartered (Jordan) pharmaceutical manufacturer with extensive generics portfolio and operations across MENA, Europe, and US. Comparable to ECMI in regional pharmaceutical market presence and government healthcare channel access.
• Sinopharm Group: China's largest state-owned pharmaceutical and healthcare distributor. Comparable to ECMI as a state-affiliated pharmaceutical distribution enterprise with national strategic role in healthcare supply chains.
• Henry Schein: Global distributor of medical, dental, and laboratory equipment and supplies. Comparable to ECMI's GOMCO subsidiary for medical equipment distribution across multiple supplier relationships.

Direct peers

• EVA Pharma: One of Egypt's largest pharmaceutical manufacturers and distributors, with operations across MENA. Directly comparable to ECMI as a major Egyptian pharmaceutical company serving both government and private healthcare channels.
• Pharco Pharmaceuticals: Egypt's largest pharmaceutical manufacturer by volume, with significant MENA export operations. Comparable to ECMI as a leading Egyptian pharma company with substantial scale and government healthcare relationships.
• EIPICO (Egyptian International Pharmaceutical Industries Company): Major Egyptian pharmaceutical manufacturer supplying both domestic and export markets. Comparable to ECMI as a long-established Egyptian pharma player with broad government and private sector reach.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/egyptian-company-for-medical-investments
• LinkedInlinkedin.com/company/egyptian-company-for-medical-investments
• Instagraminstagram.com/company/egyptian-company-for-medical-investments

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Egyptian Company for Medical Investments